6jkh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
<StructureSection load='6jkh' size='340' side='right'caption='[[6jkh]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
<StructureSection load='6jkh' size='340' side='right'caption='[[6jkh]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6jkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6JKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6JKH FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6jkh]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6JKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6JKH FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr>
 +
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">NSDHL, H105E3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/3-beta-hydroxysteroid-4-alpha-carboxylate_3-dehydrogenase_(decarboxylating) 3-beta-hydroxysteroid-4-alpha-carboxylate 3-dehydrogenase (decarboxylating)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.170 1.1.1.170] </span></td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/3-beta-hydroxysteroid-4-alpha-carboxylate_3-dehydrogenase_(decarboxylating) 3-beta-hydroxysteroid-4-alpha-carboxylate 3-dehydrogenase (decarboxylating)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.170 1.1.1.170] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6jkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6jkh OCA], [http://pdbe.org/6jkh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6jkh RCSB], [http://www.ebi.ac.uk/pdbsum/6jkh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6jkh ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6jkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6jkh OCA], [http://pdbe.org/6jkh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6jkh RCSB], [http://www.ebi.ac.uk/pdbsum/6jkh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6jkh ProSAT]</span></td></tr>
Line 12: Line 13:
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/NSDHL_HUMAN NSDHL_HUMAN]] Involved in the sequential removal of two C-4 methyl groups in post-squalene cholesterol biosynthesis.<ref>PMID:14506130</ref>
[[http://www.uniprot.org/uniprot/NSDHL_HUMAN NSDHL_HUMAN]] Involved in the sequential removal of two C-4 methyl groups in post-squalene cholesterol biosynthesis.<ref>PMID:14506130</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
NAD(P)-dependent steroid dehydrogenase-like (NSDHL), an essential enzyme in human cholesterol synthesis and a regulator of epidermal growth factor receptor (EGFR) trafficking pathways, has attracted interest as a therapeutic target due to its crucial relevance to cholesterol-related diseases and carcinomas. However, the development of pharmacological agents for targeting NSDHL has been hindered by the absence of the atomic details of NSDHL. In this study, we reported two X-ray crystal structures of human NSDHL, which revealed a detailed description of the coenzyme-binding site and the unique conformational change upon the binding of a coenzyme. A structure-based virtual screening and biochemical evaluation were performed and identified a novel inhibitor for NSDHL harboring suppressive activity towards EGFR. In EGFR-driven human cancer cells, treatment with the potent NSDHL inhibitor enhanced the antitumor effect of an EGFR kinase inhibitor. Overall, these findings could serve as good platforms for the development of therapeutic agents against NSDHL-related diseases.
 +
 +
Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity.,Kim DG, Cho S, Lee KY, Cheon SH, Yoon HJ, Lee JY, Kim D, Shin KS, Koh CH, Koo JS, Choi Y, Lee HH, Oh YK, Jeong YS, Chung SJ, Baek M, Jung KY, Lim HJ, Kim HS, Park SJ, Lee JY, Lee SJ, Lee BJ Cell Mol Life Sci. 2020 Mar 5. pii: 10.1007/s00018-020-03490-2. doi:, 10.1007/s00018-020-03490-2. PMID:32140747<ref>PMID:32140747</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 6jkh" style="background-color:#fffaf0;"></div>
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
 +
[[Category: Human]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Kim, D]]
[[Category: Kim, D]]

Revision as of 10:13, 18 March 2020

cholesterol-decarboxylating enzyme 2

PDB ID 6jkh

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools